S. Cinieri Et Al. , "Three-arm randomized phase II study evaluating oral vinorelbine plus capecitabine versus paclitaxel plus gemcitabine versus docetaxel plus gemcitabine as first-line chemotherapy in patients with metastatic breast cancer: Final results (NorCap-CA223 trial)," 50th Annual Meeting of the American-Society-of-Clinical-Oncology , vol.32, Illinois, United States Of America, 2014
Cinieri, S. Et Al. 2014. Three-arm randomized phase II study evaluating oral vinorelbine plus capecitabine versus paclitaxel plus gemcitabine versus docetaxel plus gemcitabine as first-line chemotherapy in patients with metastatic breast cancer: Final results (NorCap-CA223 trial). 50th Annual Meeting of the American-Society-of-Clinical-Oncology , (Illinois, United States Of America).
Cinieri, S., Chan, A., Altundag, K., Vandebroek, A., Tubiana-Mathieu, N., Barnadas, A., ... Dodyk, P.(2014). Three-arm randomized phase II study evaluating oral vinorelbine plus capecitabine versus paclitaxel plus gemcitabine versus docetaxel plus gemcitabine as first-line chemotherapy in patients with metastatic breast cancer: Final results (NorCap-CA223 trial) . 50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, United States Of America
Cinieri, Saverio Et Al. "Three-arm randomized phase II study evaluating oral vinorelbine plus capecitabine versus paclitaxel plus gemcitabine versus docetaxel plus gemcitabine as first-line chemotherapy in patients with metastatic breast cancer: Final results (NorCap-CA223 trial)," 50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, United States Of America, 2014
Cinieri, Saverio Et Al. "Three-arm randomized phase II study evaluating oral vinorelbine plus capecitabine versus paclitaxel plus gemcitabine versus docetaxel plus gemcitabine as first-line chemotherapy in patients with metastatic breast cancer: Final results (NorCap-CA223 trial)." 50th Annual Meeting of the American-Society-of-Clinical-Oncology , Illinois, United States Of America, 2014
Cinieri, S. Et Al. (2014) . "Three-arm randomized phase II study evaluating oral vinorelbine plus capecitabine versus paclitaxel plus gemcitabine versus docetaxel plus gemcitabine as first-line chemotherapy in patients with metastatic breast cancer: Final results (NorCap-CA223 trial)." 50th Annual Meeting of the American-Society-of-Clinical-Oncology , Illinois, United States Of America.
@conferencepaper{conferencepaper, author={Saverio Cinieri Et Al. }, title={Three-arm randomized phase II study evaluating oral vinorelbine plus capecitabine versus paclitaxel plus gemcitabine versus docetaxel plus gemcitabine as first-line chemotherapy in patients with metastatic breast cancer: Final results (NorCap-CA223 trial)}, congress name={50th Annual Meeting of the American-Society-of-Clinical-Oncology}, city={Illinois}, country={United States Of America}, year={2014}}